NO20025461L - Nye formuleringer av <alfa>-(2,4-disulfofenyl)-N-tert- butylnitron - Google Patents

Nye formuleringer av <alfa>-(2,4-disulfofenyl)-N-tert- butylnitron

Info

Publication number
NO20025461L
NO20025461L NO20025461A NO20025461A NO20025461L NO 20025461 L NO20025461 L NO 20025461L NO 20025461 A NO20025461 A NO 20025461A NO 20025461 A NO20025461 A NO 20025461A NO 20025461 L NO20025461 L NO 20025461L
Authority
NO
Norway
Prior art keywords
disulfophenyl
butylnitron
tert
alpha
new formulations
Prior art date
Application number
NO20025461A
Other languages
English (en)
Norwegian (no)
Other versions
NO20025461D0 (no
Inventor
Mats J Andersson
Mattias Andersson
Patrik Eriksson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20025461D0 publication Critical patent/NO20025461D0/no
Publication of NO20025461L publication Critical patent/NO20025461L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20025461A 2000-05-23 2002-11-14 Nye formuleringer av <alfa>-(2,4-disulfofenyl)-N-tert- butylnitron NO20025461L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0001916A SE0001916D0 (sv) 2000-05-23 2000-05-23 Novel formulation
PCT/SE2001/001164 WO2001089507A1 (en) 2000-05-23 2001-05-22 NOVEL FORMULATIONS OF α-2,4-DISULFOPHENYL-N-TERT-BUTYLNITRONE

Publications (2)

Publication Number Publication Date
NO20025461D0 NO20025461D0 (no) 2002-11-14
NO20025461L true NO20025461L (no) 2002-11-14

Family

ID=20279797

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025461A NO20025461L (no) 2000-05-23 2002-11-14 Nye formuleringer av <alfa>-(2,4-disulfofenyl)-N-tert- butylnitron

Country Status (29)

Country Link
US (2) US20030181527A1 (pl)
EP (1) EP1294369B1 (pl)
JP (1) JP3744857B2 (pl)
KR (1) KR20030001545A (pl)
CN (1) CN1268326C (pl)
AR (1) AR030218A1 (pl)
AT (1) ATE303803T1 (pl)
AU (2) AU2001260935B2 (pl)
BR (1) BR0111055A (pl)
CA (1) CA2408781A1 (pl)
CZ (1) CZ20023849A3 (pl)
DE (1) DE60113255T2 (pl)
DK (1) DK1294369T3 (pl)
EE (1) EE200200653A (pl)
ES (1) ES2247112T3 (pl)
HU (1) HUP0302310A3 (pl)
IL (1) IL152533A0 (pl)
IS (1) IS6610A (pl)
MX (1) MXPA02011533A (pl)
MY (1) MY130445A (pl)
NO (1) NO20025461L (pl)
NZ (1) NZ522329A (pl)
PL (1) PL361284A1 (pl)
RU (1) RU2271800C2 (pl)
SE (1) SE0001916D0 (pl)
SK (1) SK16542002A3 (pl)
TW (1) TWI259078B (pl)
WO (1) WO2001089507A1 (pl)
ZA (1) ZA200208747B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050182060A1 (en) * 2004-02-13 2005-08-18 Kelly Michael G. 2-Substituted and 4-substituted aryl nitrone compounds
US9265834B2 (en) 2009-03-05 2016-02-23 Ablynx N.V. Stable formulations of polypeptides and uses thereof
WO2010100135A1 (en) 2009-03-05 2010-09-10 Ablynx N.V. Novel antigen binding dimer-complexes, methods of making/avoiding and uses thereof
AU2010289838C1 (en) * 2009-08-24 2014-03-06 Hough Ear Institute Methods for treating acute acoustic trauma
LT2805731T (lt) * 2009-09-03 2019-02-11 Ablynx N.V. Stabilios polipeptidų kompozicijos ir jų panaudojimas
EP2512489A4 (en) * 2009-12-15 2014-04-02 Merck Sharp & Dohme FORMULATIONS FROM ACADESIN
ES2893825T3 (es) 2011-02-04 2022-02-10 Hough Ear Inst Métodos de tratamiento de lesiones cerebrales
US9669048B2 (en) * 2012-10-25 2017-06-06 Fresenius Kabi Oncology Limited Stable pharmaceutical composition of 5-aza-2′-deoxycitidine
US10660851B2 (en) 2015-01-02 2020-05-26 Rxos Medical Polyfunctional radical scavenger hydrogel formulation
CN116650411A (zh) * 2022-02-25 2023-08-29 广州喜鹊医药有限公司 一种注射用硝酮嗪药物组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0496796B1 (en) * 1989-10-17 1994-08-31 Oklahoma Medical Research Foundation Method and compositions for inhibition of disorders associated with oxidative damage
JP2813023B2 (ja) * 1990-03-13 1998-10-22 株式会社神戸製鋼所 Ｍｉｓ型ダイヤモンド電界効果トランジスタ
US5488145A (en) * 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps

Also Published As

Publication number Publication date
HK1051649A1 (en) 2003-08-15
DE60113255T2 (de) 2006-06-08
CN1268326C (zh) 2006-08-09
JP2003534276A (ja) 2003-11-18
SK16542002A3 (sk) 2003-04-01
CZ20023849A3 (cs) 2003-05-14
CN1430510A (zh) 2003-07-16
NZ522329A (en) 2004-07-30
ATE303803T1 (de) 2005-09-15
NO20025461D0 (no) 2002-11-14
HUP0302310A3 (en) 2005-06-28
IL152533A0 (en) 2003-05-29
RU2271800C2 (ru) 2006-03-20
ZA200208747B (en) 2004-02-10
AU6093501A (en) 2001-12-03
EE200200653A (et) 2004-06-15
EP1294369B1 (en) 2005-09-07
RU2002129588A (ru) 2004-03-27
TWI259078B (en) 2006-08-01
US20080161406A1 (en) 2008-07-03
BR0111055A (pt) 2003-04-15
SE0001916D0 (sv) 2000-05-23
KR20030001545A (ko) 2003-01-06
AR030218A1 (es) 2003-08-13
ES2247112T3 (es) 2006-03-01
DE60113255D1 (de) 2005-10-13
CA2408781A1 (en) 2001-11-29
PL361284A1 (pl) 2004-10-04
US20030181527A1 (en) 2003-09-25
AU2001260935B2 (en) 2005-05-19
MXPA02011533A (es) 2003-04-25
JP3744857B2 (ja) 2006-02-15
HUP0302310A2 (hu) 2003-11-28
DK1294369T3 (da) 2005-11-14
IS6610A (is) 2002-11-11
EP1294369A1 (en) 2003-03-26
WO2001089507A1 (en) 2001-11-29
MY130445A (en) 2007-06-29

Similar Documents

Publication Publication Date Title
BR0107565A (pt) Formas de dosagem de benzimidazol substituìdo e método de emprego das mesmas
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
SE0100901D0 (sv) New composition
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
EA200501901A1 (ru) Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путём
SE0101932D0 (sv) Pharmaceutical combinations
NO20034863D0 (no) Deuterert 3-piperidinopropiofenon og medikamenter inneholdende disse
DE60205899D1 (en) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
ATE325135T1 (de) 2-alkylierte cyclodextrinderivate : umkehrungsmittel von medikament-induzierter neuromuskulärer blockierung
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
ATE389655T1 (de) Pyrimidinderivate
ITMI992107A0 (it) Uso del baclofen nel trattamento dell&#39;astinenza da etanolo
HRP20050439B1 (hr) Nova upotreba dekstran sulfata
EA200300110A1 (ru) Композиция элетриптана в виде частиц
HRP20040383B1 (hr) Ne-neurotoksični faktori aktivacije plazminogena za liječenje moždanog udara
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
DE60121048D1 (de) PYRAZINOi1&#39;2&#39;:1,6öPYRIDOi3,4-BöINDOLDERIVATE
BR0314139A (pt) Derivados de 1,4-pirazina substituìdos
CY1108053T1 (el) Ενωση της κυαμεμαζινης και ενος ατυπου νευροληπτικου
BR0210632A (pt) Tratamento de doença parasìtica
YU87501A (sh) Farmaceutski kompleksi
ECSP045210A (es) 2&#39; - halo - 3&#39; , 5&#39; - dialcoxi - fen - 1&#39; - il - imino - 2 -imidazolidinas y su uso como un fármaco
AR023452A1 (es) Utilizacion del osanetant para preparacion de medicamentos utiles en el tratamiento de los trastornos del humor